| |
 |
 |
 |
 |
 |
 |
 |
July 28, 2003
| Key Japanese
patent issued covering HGF gene therapy |
 |
|
|
AnGes MG today announced the issuance of a Japanese
patent (JP3431633B2) covering HGF gene therapy.
Specifically, it claims a medicament for treating disease for
which HGF is effective, comprising intramuscular administration
of an expression vector containing an HGF gene. On the basis
of the Company's R&D in treatment of peripheral arterial
diseases / ischemic heart disease, the patent will support the
Company's expanding the medicine's scope of applications, as
well as promote the Company's projects related to clinical trials
for HGF genetic medicine.
Corresponding patents were established abroad to effectively
protect the clinical development globally.
US patent 6248722
Australian patent 745887
New Zealand patent 315769
Taiwanese patent 165197
In addition, patents are pending in Europe, Canada, China, and
Korea.
Finally, additional medical use patent applications were filed
subsequently to reinforce this key patent, for enhancing HGF
gene therapy and expanding its scope. |
|
|
